Similarly, inhibitors of lactate dehydrogenase A (LDHA) and monocarboxylate transporters (MCTs) disrupt lactate metabolism, reducing acidification of the tumor microenvironment and impairing tumor survival[38]. Here, LDHA is linked to neoplasm.